Adenomyosis: what is the impact on fertility? von Matalliotakis, Ioannis M, Katsikis, Ilias K, Panidis, Dimitrios K

Volltext

Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study von Panidis, Dimitrios, Tziomalos, Konstantinos, Misichronis, Georgios, Papadakis, Efstathios, Betsas, George, Katsikis, Ilias, Macut, Djuro

Volltext

Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome von Tziomalos, Konstantinos, Katsikis, Ilias, Papadakis, Efstathios, Kandaraki, Eleni A., Macut, Djuro, Panidis, Dimitrios

Volltext

Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS) von Georgopoulos, Neoklis A., Papadakis, Efstathios, Armeni, Anastasia K., Katsikis, Ilias, Roupas, Nikolaos D., Panidis, Dimitrios

Volltext

Serum Anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum Follicle Stimulating Hormone (FSH) levels von Panidis, Dimitrios, Katsikis, Ilias, Karkanaki, Artemis, Piouka, Athanasia, Armeni, Anastasia K, Georgopoulos, Neoklis A

Volltext

Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome von Vosnakis, Christos, Georgopoulos, Neoklis A, Armeni, Anastasia K, Papadakis, Efstathios, Roupas, Nikolaos D, Katsikis, Ilias, Panidis, Dimitrios

Volltext